Barbara-Jean Bormann-Kennedy

Barbara-Jean Bormann-Kennedy

Director/Board Member bei BIOLINERX LTD.

Vermögen: 127 075 $ am 31.03.2024

65 Jahre
Health Technology
Consumer Services
Health Services

Profil

Barbara-Jean Bormann-Kennedy is currently serving as a Director at Rincon Pharmaceuticals, Inc. and Biotechnology Innovation Organization.
She is also an Independent Director at BioLineRx Ltd., Director at Institute For Pediatric Innovation, Inc., Independent Non-Executive Director at Xeris Biopharma Holdings, Inc., Director at Nanomedical Systems, Inc., and VP-Translational Science & Network Alliances at The Jackson Laboratory.
In her former positions, Dr. Bormann-Kennedy served as President, Chief Executive Officer & Director at BetterLife Pharma, Inc., Chief Executive Officer & Director at Harbour Antibodies BV, Chief Executive Officer & Director at Supportive Therapeutics, and Independent Non-Executive Director at Xeris Pharmaceuticals, Inc. She also held the position of Head-Strategic Alliances at Pfizer Inc. and Senior VP-Business Development & Licensing at Boehringer Ingelheim Pharmaceuticals, Inc. Additionally, she worked as a Consultant at Paperboy Ventures LLC.
Dr. Bormann-Kennedy obtained her undergraduate degree from Fairfield University and her doctorate degree from the University of Connecticut Health Center.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
07.06.2023 57 500 ( 0,04% ) 127 075 $ 31.03.2024
15.03.2024 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Barbara-Jean Bormann-Kennedy

UnternehmenPositionBeginn
BIOLINERX LTD. Director/Board Member 19.08.2013
XERIS BIOPHARMA HOLDINGS, INC. Director/Board Member 05.10.2021
Director/Board Member -
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal 01.08.2017
Director/Board Member -
Alle aktiven Positionen von Barbara-Jean Bormann-Kennedy

Ehemalige bekannte Positionen von Barbara-Jean Bormann-Kennedy

UnternehmenPositionEnde
Director/Board Member 05.10.2021
Supportive Therapeutics Chief Executive Officer 01.07.2017
░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Barbara-Jean Bormann-Kennedy im Detail an

Ausbildung von Barbara-Jean Bormann-Kennedy

Fairfield University Undergraduate Degree
University of Connecticut Health Center Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Barbara-Jean Bormann-Kennedy im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
PFIZER, INC.

Health Technology

BETTERLIFE PHARMA INC.

Health Technology

BIOLINERX LTD.

Health Technology

XERIS BIOPHARMA HOLDINGS, INC.

Health Technology

Private Unternehmen10

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Services

Health Services

Supportive Therapeutics

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Barbara-Jean Bormann-Kennedy